Market Cap 42.89M
Revenue (ttm) 0.00
Net Income (ttm) -13.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 34,600
Avg Vol 58,502
Day's Range N/A - N/A
Shares Out 13.97M
Stochastic %K 12%
Beta 1.34
Analysts Strong Sell
Price Target $17.00

Company Profile

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also d...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 952 5500
Address:
505 Coast Boulevard South, Suite 307, La Jolla, United States
pablo4
pablo4 Oct. 16 at 5:34 PM
$CALC tick tock....when does the bomb go off here?
0 · Reply
MrAlientrader
MrAlientrader Oct. 14 at 8:06 PM
$CALC the price manipulation back again mean big upside is coming in the near future. They always come to manipulate the price down and the accumulate the most before big pop
0 · Reply
pablo4
pablo4 Oct. 13 at 5:22 PM
$CALC somebody keeps trying to pin this one in place.....but some major news is getting closer and closer....the coming phase 2 update on the AKI trial is very significant IMO. Yes, it's still a few months away but starting to get close enough for speculation to drive this seller out of Dodge, IMO.
0 · Reply
InfinityVenom
InfinityVenom Oct. 10 at 7:45 PM
$CALC bullshit as usual. thanks trump for tweating and fucking it up. we had a good breakout going
0 · Reply
pablo4
pablo4 Oct. 10 at 3:36 PM
$CALC is trying to buck the trend.....Trump has responded to China's monopolistic moves on withholding raw earth materials by threatening massive new tariffs. The market is deep red now after opening strong again. CALC is behind on getting its due relative to some other bios in the recent biotech bull run. Let's see how it does in all this.
0 · Reply
kshonstocks
kshonstocks Oct. 10 at 2:20 PM
$CALC on scans, trying for the higher highs
0 · Reply
pablo4
pablo4 Oct. 10 at 2:05 PM
$CALC one more.....could it fall back again? Yes, anything's possible in the stock market. But, don't say someone didn't offer an opinion that one might be close to missing the boat here and now. JMO.
0 · Reply
pablo4
pablo4 Oct. 10 at 1:50 PM
$CALC I believe shares are drying up at this low to mid 3s level and we will move solidly into the 4s or 5s very soon. Of course, that's just opinion. But with a strong biotech market tailwind (finally) and major CALC catalysts nearing by the day....not to mention all the aggressive insider buying....this thing is on the launching pad, IMO.
0 · Reply
pablo4
pablo4 Oct. 10 at 1:41 PM
$CALC she's gonna' rip. JMO
0 · Reply
InfinityVenom
InfinityVenom Oct. 10 at 12:45 PM
$CALC Breakout next week IMO
0 · Reply
Latest News on CALC
CalciMedica Announces Presentations at Upcoming Medical Meetings

Apr 17, 2025, 7:00 AM EDT - 6 months ago

CalciMedica Announces Presentations at Upcoming Medical Meetings


CalciMedica Secures Credit Facility for Up to $32.5 Million

Mar 5, 2025, 7:00 AM EST - 8 months ago

CalciMedica Secures Credit Facility for Up to $32.5 Million


CalciMedica Set to Join Russell Microcap® Index

Jul 1, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Set to Join Russell Microcap® Index


CalciMedica Announces Relisting on Nasdaq

Jun 12, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces Relisting on Nasdaq


CalciMedica Expands Executive Team with New Appointments

May 23, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Expands Executive Team with New Appointments


pablo4
pablo4 Oct. 16 at 5:34 PM
$CALC tick tock....when does the bomb go off here?
0 · Reply
MrAlientrader
MrAlientrader Oct. 14 at 8:06 PM
$CALC the price manipulation back again mean big upside is coming in the near future. They always come to manipulate the price down and the accumulate the most before big pop
0 · Reply
pablo4
pablo4 Oct. 13 at 5:22 PM
$CALC somebody keeps trying to pin this one in place.....but some major news is getting closer and closer....the coming phase 2 update on the AKI trial is very significant IMO. Yes, it's still a few months away but starting to get close enough for speculation to drive this seller out of Dodge, IMO.
0 · Reply
InfinityVenom
InfinityVenom Oct. 10 at 7:45 PM
$CALC bullshit as usual. thanks trump for tweating and fucking it up. we had a good breakout going
0 · Reply
pablo4
pablo4 Oct. 10 at 3:36 PM
$CALC is trying to buck the trend.....Trump has responded to China's monopolistic moves on withholding raw earth materials by threatening massive new tariffs. The market is deep red now after opening strong again. CALC is behind on getting its due relative to some other bios in the recent biotech bull run. Let's see how it does in all this.
0 · Reply
kshonstocks
kshonstocks Oct. 10 at 2:20 PM
$CALC on scans, trying for the higher highs
0 · Reply
pablo4
pablo4 Oct. 10 at 2:05 PM
$CALC one more.....could it fall back again? Yes, anything's possible in the stock market. But, don't say someone didn't offer an opinion that one might be close to missing the boat here and now. JMO.
0 · Reply
pablo4
pablo4 Oct. 10 at 1:50 PM
$CALC I believe shares are drying up at this low to mid 3s level and we will move solidly into the 4s or 5s very soon. Of course, that's just opinion. But with a strong biotech market tailwind (finally) and major CALC catalysts nearing by the day....not to mention all the aggressive insider buying....this thing is on the launching pad, IMO.
0 · Reply
pablo4
pablo4 Oct. 10 at 1:41 PM
$CALC she's gonna' rip. JMO
0 · Reply
InfinityVenom
InfinityVenom Oct. 10 at 12:45 PM
$CALC Breakout next week IMO
0 · Reply
pablo4
pablo4 Oct. 9 at 7:40 PM
$CALC it's time for a big breakout here, IMO.....the whole small bio sector is roaring and CALC has the best of reasons to do so....chronic insider buying!
0 · Reply
MrAlientrader
MrAlientrader Oct. 9 at 6:39 PM
$CALC i don’t care market reaction i just keep buying the dip like the insiders doing. Set sell price $10+ and thank me later
0 · Reply
Stmkr
Stmkr Oct. 6 at 2:31 PM
$CALC Is this trading under the radar?? - Readout in early 2026 within cash runway. Positive readout would mean targeting a $10B market - Multiple proof-of-concept data from prior RCTs (albeit small) somewhat derisk the study - Insiders keep buying
0 · Reply
Stmkr
Stmkr Oct. 4 at 5:19 PM
$CALC CBO keeps buying here. I see around 50K shares just the last couple of months
0 · Reply
Stmkr
Stmkr Oct. 3 at 3:48 PM
$CALC confused about which the primary endpoint is? Different outcome in company's presentation vs clinicaltrials.gov and the publication
1 · Reply
pablo4
pablo4 Oct. 2 at 6:50 PM
$CALC is a company with great results so far on treatments for acute kidney injury and acute pancreatitis, potential billion dollar markets for CALC......insiders here have bought during their open insider buying window (closed right now) actively and often. Results from the acute kidney injury phase 2 are not far away nor is it long before the pivotal phase 3 trial for acute pancreatitis starts enrolling. And, yet, the market cap sits around 42M. When will this explode....it's a comin', IMO.
1 · Reply
pablo4
pablo4 Sep. 24 at 3:10 PM
$CALC who keeps selling shares in CALC when insiders are buying super actively around and well above the price you're selling at?
0 · Reply
pablo4
pablo4 Sep. 22 at 2:36 PM
$CALC https://www.sec.gov/Archives/edgar/data/1534133/000157624425000007/xslF345X05/form4-09222025_090901.xml This guy is going to buy us out if he keeps going.....just kidding but this insider buying is non-stop.
0 · Reply
SteepDescent_
SteepDescent_ Sep. 21 at 10:04 AM
$CALC Exactly one economic step is still pending: “First draw funded (Tranche 2 or Tranche 3)” as the windows have now opened and remain available. Fast mover. High torque.
0 · Reply
_CCS_
_CCS_ Sep. 18 at 8:04 PM
$CALC gap fill under 2$
1 · Reply
pablo4
pablo4 Sep. 17 at 3:54 PM
$CALC one more....I find it hard to believe this stock is still below 5/share. Management couldn't shout louder its confidence in its therapy. We say, put your money where your mouth is....well, they are sure doing that. Of course, the stock price staying down has allowed for people (including myself) to build a larger position before the speculation builds....and, IMO, it will build since mgt buying behavior is ample to fuel that speculation, IMO.
0 · Reply
pablo4
pablo4 Sep. 17 at 2:52 PM
$CALC I am pumped about this one. Over the decades of investing, I've never seen the buying activity of this CALC mgt team in terms of regularity. There have been numerous, numerous buys over recent months. There's key data coming up around the coming new year. The acute kidney injury and acute pancreatitis markets (size of unmet need) it huge. And, clearly, by the buying activity, CALC mgt believes in its treatment in development. JMO
0 · Reply